The US Environmental Protection Agency (EPA) has long maintained that the herbicide is safe for use under strict ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

Neurological conditions are now the leading cause of ill health worldwide, yet remain an enigma. Meet the patients who baffle ...

For the people it affects (and anyone who shares a bed with them) restless legs syndrome (RLS) is a torturous condition.

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

It can improve motor symptoms, including tremors. Deep brain stimulation (DBS) will continue to see high usage in Parkinson’s ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In Episode 746 of Power Athlete Radio, Dr. Adeel Khan dives into cutting-edge advancements in regenerative medicine, focusing on induced pluripotent stem cells ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Regenerative medicine is an exciting field with a promising future, capable of tackling inherent challenges seen with current therapies.